Condition 1: Investigation of the comparative effectiveness between Achillea wilhelmsii consumption and counseling with mindfulness-based cognitive therapy (MBCT) approach on hot flashes, in menopausal women. Condition 2: Comparative study of the effect of Achillea wilhelmsii and counseling with mindfulness-based cognitive therapy approach on quality of life in postmenopausal women. Condition 3: Comparative study of the effect of Achillea wilhelmsii and counseling with mindfulness-based cog
Conditions
Interventions
Intervention 1: Intervention group: Achillea wilhelmsii capsule (2 mg daily in the morning and evening for 2 months) which contains Achillea wilhelmsii which has phytoestrogenic properties and is p
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Be literate All Women are 65-45 Have at least 3- 20 hot flashes a day For one year after the last menstrual period
Exclusion criteria
Exclusion criteria: Absence from two sessions of medical counseling Have a physical or mental illness Have a regular exercise program Taking psychotropic drugs Have a severely stressful event over the past month Has taken less than 80% of his medication Has used soy or phytoestrogens more than once in the past week Over the past week with a specific illness that is severely stressful or causing pain During the study, he had to use a special medication that caused sleep disturbances as well as hot flashes Have changed your sleeping place and place during the last week Used sleeping pills or hypnotics He has used psychedelic, sedative and anti-anxiety drugs Be addicted to drugs such as cigarettes and alcohol Use medications that cause sleep disturbances or insomnia History of yarrow or any of its components, people with allergic asthma, seizures, liver disease or cancer Take any estrogen-based medication to treat menopausal complications (osteoporosis, hot flashes) or other interfering medications such as tibolone with a night shift job. Menopause due to bilateral removal of the ovaries or undergoing chemotherapy Treatment for mental disorders or hot flashes in the last 60 days Hormone Therapy Use of hormonal contraceptives Taking selective estrogen receptor modulators or aromatase inhibitors over the past two months Have severe depression Have a severe current illness Suicide attempt in the last 3 weeks Having bipolar disorder or other mental disorders throughout life Uncontrolled blood pressure Taking tamoxifen, raloxifene, antidepressant, clonidine in the last two months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Flush score. Timepoint: Measure hot flashes before the study and at the end of the first and second months. Method of measurement: Flushing severity questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactOmolbanin Lotfi
Kerman University of Medical Sciences
Outcome results
None listed